| A meta‐analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma G Cabibbo, M Enea, M Attanasio, J Bruix, A Craxì, C Cammà Hepatology 51 (4), 1274-1283, 2010 | 544 | 2010 |
| Field‐practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy M Iavarone, G Cabibbo, F Piscaglia, C Zavaglia, A Grieco, E Villa, ... Hepatology, 2011 | 419 | 2011 |
| Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease F Bortolotti, G Verucchi, C Cammà, G Cabibbo, L Zancan, G Indolfi, ... Gastroenterology 134 (7), 1900-1907, 2008 | 347* | 2008 |
| Incidence of hepatocellular carcinoma in patients with HCV-associated cirrhosis treated with direct-acting antiviral agents V Calvaruso, G Cabibbo, I Cacciola, S Petta, S Madonia, A Bellia, F Tinè, ... Gastroenterology 155 (2), 411-421. e4, 2018 | 332 | 2018 |
| Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study E Villa, R Critelli, B Lei, G Marzocchi, C Cammà, G Giannelli, P Pontisso, ... Gut 65 (5), 861-869, 2016 | 236 | 2016 |
| Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study A Vitale, P Burra, AC Frigo, F Trevisani, F Farinati, G Spolverato, M Volk, ... Journal of hepatology 62 (3), 617-624, 2015 | 224 | 2015 |
| Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules E Terzi, M Iavarone, M Pompili, L Veronese, G Cabibbo, M Fraquelli, ... Journal of hepatology 68 (3), 485-492, 2018 | 214 | 2018 |
| HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: a meta-analysis AG Singal, E Zhang, M Narasimman, NE Rich, AK Waljee, Y Hoshida, ... Journal of hepatology 77 (1), 128-139, 2022 | 195 | 2022 |
| Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients G Cabibbo, C Celsa, V Calvaruso, S Petta, I Cacciola, MR Cannavò, ... Journal of hepatology 71 (2), 265-273, 2019 | 169* | 2019 |
| Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers? G Marisi, A Cucchetti, P Ulivi, M Canale, G Cabibbo, L Solaini, FG Foschi, ... World journal of gastroenterology 24 (36), 4152, 2018 | 169 | 2018 |
| The impact of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data F Fiorica, F Cartei, M Enea, A Licata, G Cabibbo, B Carau, A Liboni, ... Cancer treatment reviews 33 (8), 729-740, 2007 | 166 | 2007 |
| Effects of eradicating hepatitis C virus infection in patients with cirrhosis differ with stage of portal hypertension V Di Marco, V Calvaruso, D Ferraro, MG Bavetta, G Cabibbo, E Conte, ... Gastroenterology 151 (1), 130-139. e2, 2016 | 164 | 2016 |
| Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population S Bruno, V Di Marco, M Iavarone, L Roffi, A Crosignani, V Calvaruso, ... Journal of Hepatology 64 (6), 1217-1223, 2016 | 161 | 2016 |
| Staging systems of hepatocellular carcinoma: a review of literature M Maida, E Orlando, C Cammà, G Cabibbo World Journal of Gastroenterology: WJG 20 (15), 4141, 2014 | 155 | 2014 |
| Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib M Iavarone, G Cabibbo, M Biolato, C Della Corte, M Maida, M Barbara, ... Hepatology 62 (3), 784-791, 2015 | 138 | 2015 |
| Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study C Camma, V Di Marco, A Orlando, L Sandonato, A Casaril, P Parisi, ... Journal of hepatology 42 (4), 535-540, 2005 | 138* | 2005 |
| Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct‐acting antivirals? A prospective multicentre study G Cabibbo, S Petta, V Calvaruso, I Cacciola, MR Cannavò, S Madonia, ... Alimentary pharmacology & therapeutics 46 (7), 688-695, 2017 | 136 | 2017 |
| Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma A Cucchetti, F Trevisani, A Pecorelli, V Erroi, F Farinati, F Ciccarese, ... Journal of Hepatology 61 (2), 333-341, 2014 | 134 | 2014 |
| Development and validation of a new prognostic system for patients with hepatocellular carcinoma F Farinati, A Vitale, G Spolverato, TM Pawlik, T Huo, YH Lee, AC Frigo, ... PLoS medicine 13 (4), e1002006, 2016 | 131 | 2016 |
| Epidemiology, risk factors and surveillance of hepatocellular carcinoma G Cabibbo, A Craxi Eur Rev Med Pharmacol Sci 14 (4), 352-355, 2010 | 131 | 2010 |
Calogero CammàSection of Gastroenterology, University of Palermo在 unipa.it 的电子邮件经过验证
